These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 23287123)
1. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Rekhi B; Basak R; Desai SB; Jambhekar NA Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123 [TBL] [Abstract][Full Text] [Related]
2. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. Rekhi B; Vogel U APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315 [TBL] [Abstract][Full Text] [Related]
3. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Valente AL; Tull J; Zhang S Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007 [TBL] [Abstract][Full Text] [Related]
4. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features. Bakrin IH; Hussain FA; Tuan Sharif SE Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668 [TBL] [Abstract][Full Text] [Related]
5. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377 [TBL] [Abstract][Full Text] [Related]
6. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics. Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625 [TBL] [Abstract][Full Text] [Related]
7. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma. Madakshira MG; Radotra BD; Kaman L; Saikia UN Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590 [TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272 [TBL] [Abstract][Full Text] [Related]
10. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Kosemehmetoglu K; Vrana JA; Folpe AL Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472 [TBL] [Abstract][Full Text] [Related]
11. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas. Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579 [TBL] [Abstract][Full Text] [Related]
12. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma. Atef A; Alrashidy M Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872 [TBL] [Abstract][Full Text] [Related]
13. Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study. Qureshi MB; Uddin N; Tariq MU; Raheem A; Pervez S Cureus; 2019 Dec; 11(12):e6357. PubMed ID: 31938642 [TBL] [Abstract][Full Text] [Related]
14. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China. Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Kang Y; Pekmezci M; Folpe AL; Ersen A; Horvai AE Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265 [TBL] [Abstract][Full Text] [Related]
16. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma. Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of TLE1 (Transducer-Like Enhancer of Split 1) in Distinguishing Synovial Sarcoma from Mimicking Tumors. Qureshi MB; Tariq MU; Abdul-Ghafar J; Chundriger Q; Ud Din N Int J Gen Med; 2021; 14():9173-9179. PubMed ID: 34880656 [TBL] [Abstract][Full Text] [Related]
18. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China. Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493 [TBL] [Abstract][Full Text] [Related]
19. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall. Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. Ito J; Asano N; Kawai A; Yoshida A Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]